edits.seer.internal.rules.IFN3010.xml Maven / Gradle / Ivy
Go to download
Show more of this group Show more artifacts with this name
Show all versions of validation-edits-seer Show documentation
Show all versions of validation-edits-seer Show documentation
Java implemenation of the SEER edits.
<rule id="IFN3010" name="AJCC ID, Site, Histo, Schema Discriminator 1 (NAACCR)" tag="N3010" java-path="lines.line" category="inter-field" depends="Year_of_Diagnosis">
<expression><![CDATA[if (line.dateOfDiagnosisYear == null || line.dateOfDiagnosisYear < '2018')
return true
if (line.primarySite == null || line.histologicTypeIcdO3 == null || line.behaviorCodeIcdO3 == null)
return true
String ajccId = line.ajccId
Integer siteInt = Functions.asInt(line.primarySite.substring(1,4))
Map contextMap = (Map)Context.IFN3010_Table
if (!contextMap.containsKey(siteInt))
return true
else {
Map histologyMap = (Map)contextMap.get(siteInt)
Integer histInt = Functions.asInt(line.histologicTypeIcdO3)
if (!histologyMap.containsKey(histInt))
return true
Map behaviorMap = (Map)(histologyMap.get(histInt))
if (!behaviorMap.containsKey(line.behaviorCodeIcdO3))
return line.ajccId == 'XX'
List ajccIds = (List)(behaviorMap.get(line.behaviorCodeIcdO3))
if (ajccIds != null && ajccIds.contains(line.ajccId)) {
if (line.ajccId == 'XX' && line.schemaDiscriminator1 == null)
return true
Map ajccIdMap = (Map)Context.IFN3010_AJCC_ID_Table
List validDiscrims = (List)ajccIdMap.get(line.ajccId)
return validDiscrims.contains(line.schemaDiscriminator1)
}
else
return line.ajccId == 'XX'
}
return true]]></expression>
<message>Primary Site, Histologic Type ICD-O-3, and Schema Discriminator 1 are incompatible with AJCC ID.</message>
<description><![CDATA[This edit verifies that Schema Discriminator 1, where required, is used where
the Primary Site and Histologic Type ICD-O-3 codes are not sufficient to
identify the appropriate AJCC staging scheme. Schema Discriminator 1 code is
used to distinguish between multiple meanings for these codes where required
for AJCC ID assignment.
For example, for topography code C240, Schema Discriminator 1 code 3 is
assigned if the primary site is cystic duct, AJCC ID 24; code 1, 5, 6 or 9
is assigned if the primary site is perihilar bile ducts, AJCC ID 25; code
4 or 7 is assigned if the primary site is distal bile ducts, AJCC ID 26. See
the list of codes and definitions below the chart.
Schema Discriminator 1 is also used in conjunction with an SSDI for AJCC ID
82.1 to identify a plasma cell myeloma that can be assigned staging information.
The edit checks that AJCC ID, Primary Site code or Histologic Type ICD-O-3
code, and Schema Discriminator 1 code occur together within the edited
record, as shown in the following chart. Behavior Code ICD-O-3 must also be
correct for a stageable case. The edit does not check that
Schema Discriminator 1 is blank where not required for AJCC ID; Schema ID
requires Schema Discriminator 1 on additional site/histology combinations.
1. The edit is skipped for the following conditions:
a. Date of diagnosis before 2018, blank, or invalid.
b. Primary Site is blank
c. Histologic Type ICD-O-3 is blank
d. Behavior Code ICD-O-3 is blank
2. The edit checks that Schema Discriminator 1 is coded and not blank for
combinations of Primary Site and Histologic Type ICD-O-3 as required. The
combinations of site and histology are determined
by AJCC ID but are checked independently of AJCC ID assignment.
3. The edit then verifies that Schema Discriminator 1 is valid for Primary Site,
Histologic Type ICD-O-3, Behavior Code ICD-O-3, and AJCC ID. Where a specific
site or histology is listed, Schema Discriminator 1 is required for only those
sites or histologies for the AJCC ID.
4. Where Schema Discriminator 2 is also required to assign the correct AJCC ID between
two possible AJCC IDs, the edit will pass either AJCC ID as correct. The AJCC IDs
include 10 and 11.1, with histologies 8070 and 8083, and 16.1 and 16.2 with histology 8020.
AJCC ID SITE HISTO BEH DISC 1
6 Cervical Lymph Nodes,
Unknown Primary of Head and Neck C760 All 3 2,3,4,5
9 Nasopharynx C111 All 2,3 1
10 Oropharynx (p16+) C111 All 3 2
11.1 Oropharynx (p16-) C111 All 2,3 2
16.1 Esophagus and EGJ: Squamous Cell Ca C160 All 2,3 2
16.2 Esophagus and EGJ: Adenocarcinoma C160 All 2,3 2
16.3 Esophagus and EGJ: Other Histologies C160 All 2,3 2
17 Stomach C160 All 2,3 0,3,9
24 Gallbladder C240 All 2,3 3
25 Perihilar Bile Ducts C240 All 2,3 1,5,6,9
26 Distal Bile Ducts C240 All 2,3 4,7
43.1 GIST: Gastric and Omental C481 All 3 2
43.2 GIST: Small Intestinal, Esophageal, C481 All 3 1,9
Colorectal, Mesenteric, Perit
63.1 Urethra, Male Penile, Female: Uroth C680 All 2,3 1
63.2 Urethra, Male Penile, Female: C680 All 2,3 1
Squamous Cell, Adenocarcinoma
63.3 Prostatic Urethra: Urothelial C680 All 2,3 2
63.4 Prostatic Urethra: C680 All 2,3 2
Squamous Cell, Adenocarcinoma
67.1 Uveal Melanoma: Iris C694 All 3 2
67.2 Uveal Melanoma: Ciliary Body, Chor C694 All 3 1
69 Lacrimal Gland C695 All 3 1
73.1 Thyroid Gland - Differentiated C739 All 3 1
73.2 Thyroid Gland - Anaplastic C739 All 3 1
74 Thyroid - Medullary C739 All 3 1
79.0 Non-Hodgkin Lymphoma NOS All 9591 3 3,9
82.1 Plasma Cell Myeloma All 9732 3 0
83.0 Leukemia NOS All 9591 3 1,2
NOTE: Histology 8020 for 16.1,16.2 AJCC ID is only staged with Behavior code 3.
AJCC ID SCHEMA DISCRIMINATOR 1 CODES AND DEFINITIONS
6-C760 2: Not tested for EBV or p16 in head and neck regional nodes (EBV
and p16 both unknown)
3: Unknown EBV, p16 negative in head and neck regional nodes
4: Unknown p16, EBV negative in head and neck regional nodes
5: Negative for both EBV and p16 in head and neck regional nodes
9-C111 1: Posterior wall of nasopharynx, NOS
10-C111 2: Adenoid; pharyngeal tonsil
11.1-C111
16.1-C160 2: INVOLVEMENT of esophagus or esophagogastric junction (EGJ)
16.2-C160 AND epicenter LESS THAN or EQUAL TO 2 cm into the proximal
16.3-C160 stomach
17-C160 0: NO involvement of esophagus or gastroesophageal junction
AND epicenter at ANY DISTANCE into the proximal stomach
(including distance unknown)
3: INVOLVEMENT of esophagus or esophagogastric junction (EGJ)
AND epicenter GREATER THAN 2 cm into the proximal stomach
9: UNKNOWN involvement of esophagus or gastroesophageal junction
AND epicenter at ANY DISTANCE into the proximal stomach
(including distance unknown
24-C240 3: Cystic bile duct; cystic duct
25-C240 1: Perihilar bile duct(s)
Proximal extrahepatic bile duct(s); Hepatic duct(s)
5: Diffuse involvement
More than one subsite involved, subsite of origin not stated
6: Stated as middle extrahepatic bile duct
AND treated with combined hepatic and hilar resection
9: Extrahepatic bile ducts, NOS
26-C240 4: Distal bile duct; Common bile duct; Common duct, NOS
7: Stated as middle extrahepatic bile duct
AND treated with combined hepatic and hilar resection
43.1-C481 1: Mesentery; Mesoappendix; Mesocolon; Pelvic peritoneum;
Rectouterine pouch: Cul de sac, Pouch of Douglas;
Other specified peritoneal site
9: Unknown or no information; Not documented in medical record
43.2-C481 2: Omentum
63.1-C680 1: Male penile urethra; Female urethra: Urethral gland;
63.2-C680 Cowper gland; Urethra, NOS
63.3-C680 2: Males only: Prostatic urethra, Prostatic utricle
63.4-C680
67.1-C694 2: Iris
67.2-C694 1: Ciliary Body; Crystalline lens; Sclera; Uveal tract;
Intraocular; Eyeball
69-C695 1: Lacrimal gland
73.1-C739 1: Thyroid gland; Thyroid, NOS
73.2-C739
74-C739
79.0-9591 3: Splenic diffuse red pulp small B-cell lymphoma
Splenic marginal zone lymphoma, diffuse variant
Splenic red pulp lymphoma with numerous basophilic villous
lymphocytes
Splenic lymphoma with villous lymphocytes
9: Non-Hodgkin lymphoma, NOS
Any other terminology describing non-Hodgkin lymphoma, NOS
82.1-9732 0: Multiple myeloma
Myeloma, NOS
Non-secretory myeloma
Plasma cell myeloma (PCM)
Ultra-High-Risk Smoldering MM (SMM)
83.0-9591 1: Splenic B-cell lymphoma/leukemia, unclassifiable
2: Hairy cell leukemia variant
Prolymphocytic variant of hairy cell leukemia]]></description>
<history>
<event version="SE18-018-10" user="kirbyk" date="2018-12-05" ref="68065">Edit created.</event>
<event version="SE18-018-11" user="kirbyk" date="2019-01-03" ref="68081">Changed the edit so it always returns true. There are issues with the table; the edit will be ignored until those issues are resolved.</event>
<event version="SE18-019-01" user="kirbyk" date="2019-03-11" ref="68090">Fixed table values and description and turned edit back on; changed edit name.</event>
<event version="SE18-019-01" user="kirbyk" date="2019-04-16" ref="68163">Removed skip condtiion based on AJCC ID.</event>
<event version="SE18-020-01" user="depryf" date="2020-02-04" ref="68281">Changed property names to align with NAACCR XML IDs.</event>
<event version="SE21-021-04" user="kirbyk" date="2021-05-20" ref="68595">Updated edit logic and table for 2021.</event>
<event version="SE22-022-01" user="beverung" date="2022-02-24" ref="68778">Update table for 2022.</event>
<event version="SE24-024-03" user="beverung" date="2024-02-02" ref="69328">Updated table for 2024. Removed behavior codes 0,1 for AJCC IDs 43.1 and 43.2.</event>
</history>
</rule>